Filament Health Corp.
FH
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -50.36% | 40.15% | -67.38% | -89.33% | -94.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -50.36% | 40.15% | -67.38% | -89.33% | -94.48% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -50.36% | 40.15% | -67.38% | -89.33% | -94.48% |
| SG&A Expenses | -47.59% | -42.70% | -25.40% | -40.71% | -41.04% |
| Depreciation & Amortization | -2.53% | -1.28% | -5.06% | -1.02% | -0.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.84% | -42.91% | -21.16% | -45.77% | -38.98% |
| Operating Income | 44.71% | 53.17% | 0.82% | -31.17% | 22.09% |
| Income Before Tax | 34.92% | 44.97% | 12.29% | -61.76% | 26.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.92% | 46.13% | 12.29% | -61.76% | 26.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.92% | 46.13% | 12.29% | -61.76% | 26.70% |
| EBIT | 44.71% | 53.17% | 0.82% | -31.17% | 22.09% |
| EBITDA | 43.39% | 52.47% | -4.67% | -31.77% | 23.16% |
| EPS Basic | 35.71% | 52.94% | 28.13% | -40.00% | 50.00% |
| Normalized Basic EPS | 35.29% | 52.38% | 30.00% | 8.00% | 51.43% |
| EPS Diluted | 35.71% | 52.94% | 28.13% | -40.00% | 50.00% |
| Normalized Diluted EPS | 35.29% | 52.38% | 30.00% | 8.00% | 51.43% |
| Average Basic Shares Outstanding | 2.19% | 18.94% | 23.95% | 15.87% | 46.44% |
| Average Diluted Shares Outstanding | 2.19% | 18.94% | 23.95% | 15.87% | 46.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |